Latest Press Releases
More Press Releases
Imbed Biosciences Announces CMS Assignment of HCPCS Code A2040 for Microlyte® PainGuard™
MIDDLETON, Wis., April 1, 2026
MNDY Investors Have Opportunity to Lead monday.com Ltd. Securities Fraud Lawsuit
NEW YORK, April 1, 2026
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine
Prestigious Publication Reinforces risto-cel’s Durable, Differentiated Clinical Data for the Treatment of SCD with
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Gossamer
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Camping World Holdings, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Camping
QCI Introduces New Operational Solutions at IGA 2026
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) — Quick Custom Intelligence (QCI), a leading provider of AI-driven
Beyond Oil Provides Further Update on Continuance from the Province of British Columbia to the Province of Ontario and Relating Filings
Company Obtains Management Cease Trade Order Relating to Administrative Delay in Processing Continuance Which May Delay
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, April 01, 2026 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology